SG11201504520XA - Compositions and methods for capture of cellular targets of bioactive agents - Google Patents
Compositions and methods for capture of cellular targets of bioactive agentsInfo
- Publication number
- SG11201504520XA SG11201504520XA SG11201504520XA SG11201504520XA SG11201504520XA SG 11201504520X A SG11201504520X A SG 11201504520XA SG 11201504520X A SG11201504520X A SG 11201504520XA SG 11201504520X A SG11201504520X A SG 11201504520XA SG 11201504520X A SG11201504520X A SG 11201504520XA
- Authority
- SG
- Singapore
- Prior art keywords
- capture
- compositions
- methods
- bioactive agents
- cellular targets
- Prior art date
Links
- 239000012867 bioactive agent Substances 0.000 title 1
- 230000001413 cellular effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261736426P | 2012-12-12 | 2012-12-12 | |
| US201361788313P | 2013-03-15 | 2013-03-15 | |
| PCT/US2013/074756 WO2014093671A1 (en) | 2012-12-12 | 2013-12-12 | Compositions and methods for capture of cellular targets of bioactive agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201504520XA true SG11201504520XA (en) | 2015-07-30 |
Family
ID=50934961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504520XA SG11201504520XA (en) | 2012-12-12 | 2013-12-12 | Compositions and methods for capture of cellular targets of bioactive agents |
Country Status (11)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5882904B2 (ja) | 2009-12-09 | 2016-03-09 | ザ プロクター アンド ギャンブルカンパニー | 布地ケア製品及びホームケア製品 |
| US9056885B2 (en) * | 2011-11-21 | 2015-06-16 | Promega Corporation | Carboxy X rhodamine analogs |
| SG11201504520XA (en) | 2012-12-12 | 2015-07-30 | Promega Corp | Compositions and methods for capture of cellular targets of bioactive agents |
| US10168323B2 (en) | 2013-03-15 | 2019-01-01 | Promega Corporation | Compositions and methods for capture of cellular targets of bioactive agents |
| JP6604938B2 (ja) * | 2013-03-15 | 2019-11-13 | プロメガ コーポレイション | タンパク質を官能基または固体表面に共有結合的に係留するための基質 |
| US10618907B2 (en) | 2015-06-05 | 2020-04-14 | Promega Corporation | Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements |
| US10458988B2 (en) * | 2017-03-03 | 2019-10-29 | Musc Foundation For Research Development | Biotinylated luminescent probe |
| US11709155B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US11709156B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved analytical analysis |
| US12181452B2 (en) | 2017-09-18 | 2024-12-31 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US12180581B2 (en) | 2017-09-18 | 2024-12-31 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US11913944B2 (en) | 2019-03-20 | 2024-02-27 | Promega Corporation | Photoaffinity probes |
| US11918936B2 (en) | 2020-01-17 | 2024-03-05 | Waters Technologies Corporation | Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding |
| US12352734B2 (en) | 2020-09-24 | 2025-07-08 | Waters Technologies Corporation | Chromatographic hardware improvements for separation of reactive molecules |
| JP2022182394A (ja) * | 2021-05-28 | 2022-12-08 | 独立行政法人国立病院機構 | 抗原固相化デバイス |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5914095A (en) | 1989-04-07 | 1999-06-22 | Salutar, Inc. | Polychelants containg amide bonds |
| US5344926A (en) | 1992-06-22 | 1994-09-06 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing staurosporine derivatives |
| KR950703582A (ko) | 1992-10-14 | 1995-09-20 | 조이스 이. 마임스 | 킬레이트화 중합체(chelating polymers) |
| US5756688A (en) | 1992-10-14 | 1998-05-26 | Sterling Winthrop Inc. | MR imaging compositions and methods |
| GB9503969D0 (en) | 1995-02-28 | 1995-04-19 | Sams Bernard | Incrementing mechanism |
| CA2398010A1 (en) | 2000-01-24 | 2001-07-26 | The Trustees Of Columbia University In The City Of New York | An in vivo screen using chemical inducers of dimerization |
| US20020168737A1 (en) | 2001-01-24 | 2002-11-14 | Cornish Virginia W. | Binding and catalysis screen for high throughput determination of protein function using chemical inducers of dimerization |
| EP2353611B1 (en) * | 2002-07-31 | 2015-05-13 | Seattle Genetics, Inc. | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| US7429472B2 (en) | 2003-01-31 | 2008-09-30 | Promega Corporation | Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule |
| EP2369006B1 (en) | 2003-01-31 | 2014-03-12 | Promega Corporation | Covalent tethering of functional groups to proteins |
| KR100507796B1 (ko) * | 2003-04-03 | 2005-08-17 | 한미약품 주식회사 | 생체내 반감기가 증가된 ｐｅｇ-생리활성 폴리펩티드 동종이량체 결합체 및 이의 제조방법 |
| US7425436B2 (en) * | 2004-07-30 | 2008-09-16 | Promega Corporation | Covalent tethering of functional groups to proteins and substrates therefor |
| US20070224620A1 (en) * | 2006-02-08 | 2007-09-27 | Promega Corporation | Compositions and methods for capturing and analyzing cross-linked biomolecules |
| JP5420198B2 (ja) * | 2008-06-16 | 2014-02-19 | オリンパス株式会社 | タンパク質相互作用解析方法、ポリヌクレオチド、および、組成物 |
| KR100891456B1 (ko) * | 2008-11-06 | 2009-04-01 | 씨지케이 주식회사 | 생리활성물질에 대한 세포내 표적물질을 검출하는 방법 및 장치 |
| SG10201601281WA (en) * | 2009-05-01 | 2016-03-30 | Promega Corp | Synthetic oplophorus luciferases with enhanced light output |
| BR112013010855A2 (pt) | 2010-11-02 | 2017-06-27 | Promega Corp | luciferases derivadas de oplophorus, novos substratos de coelenterazina e métodos de uso |
| SG11201504520XA (en) | 2012-12-12 | 2015-07-30 | Promega Corp | Compositions and methods for capture of cellular targets of bioactive agents |
| JP6604938B2 (ja) * | 2013-03-15 | 2019-11-13 | プロメガ コーポレイション | タンパク質を官能基または固体表面に共有結合的に係留するための基質 |
| US10168323B2 (en) * | 2013-03-15 | 2019-01-01 | Promega Corporation | Compositions and methods for capture of cellular targets of bioactive agents |
| US10618907B2 (en) * | 2015-06-05 | 2020-04-14 | Promega Corporation | Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements |
-
2013
- 2013-12-12 SG SG11201504520XA patent/SG11201504520XA/en unknown
- 2013-12-12 KR KR1020157018280A patent/KR102227321B1/ko active Active
- 2013-12-12 WO PCT/US2013/074756 patent/WO2014093671A1/en active Application Filing
- 2013-12-12 KR KR1020207024366A patent/KR102272233B1/ko active Active
- 2013-12-12 EP EP13862430.9A patent/EP2931305B1/en active Active
- 2013-12-12 JP JP2015547559A patent/JP6484178B2/ja active Active
- 2013-12-12 BR BR112015013715A patent/BR112015013715A2/pt not_active Application Discontinuation
- 2013-12-12 AU AU2013359160A patent/AU2013359160B2/en active Active
- 2013-12-12 CA CA2894432A patent/CA2894432C/en active Active
- 2013-12-12 US US14/104,814 patent/US9551705B2/en active Active
- 2013-12-12 CN CN201380064237.XA patent/CN104853767B/zh active Active
-
2015
- 2015-06-04 IL IL239213A patent/IL239213B/en active IP Right Grant
-
2017
- 2017-01-10 US US15/402,879 patent/US10976312B2/en active Active
-
2019
- 2019-02-14 AU AU2019201035A patent/AU2019201035B9/en active Active
- 2019-02-15 JP JP2019025449A patent/JP6999589B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013359160A1 (en) | 2015-07-09 |
| EP2931305A1 (en) | 2015-10-21 |
| JP2019092517A (ja) | 2019-06-20 |
| US9551705B2 (en) | 2017-01-24 |
| BR112015013715A2 (pt) | 2017-09-26 |
| CA2894432A1 (en) | 2014-06-19 |
| AU2013359160A2 (en) | 2015-11-12 |
| KR102272233B1 (ko) | 2021-07-01 |
| EP2931305B1 (en) | 2018-11-28 |
| WO2014093671A1 (en) | 2014-06-19 |
| EP2931305A4 (en) | 2016-08-17 |
| AU2013359160B2 (en) | 2018-11-15 |
| AU2019201035A1 (en) | 2019-03-07 |
| KR20200103867A (ko) | 2020-09-02 |
| KR20150093222A (ko) | 2015-08-17 |
| CN104853767B (zh) | 2017-04-05 |
| CN104853767A (zh) | 2015-08-19 |
| CA2894432C (en) | 2022-06-07 |
| US10976312B2 (en) | 2021-04-13 |
| US20170115283A1 (en) | 2017-04-27 |
| IL239213A0 (en) | 2015-07-30 |
| JP6999589B2 (ja) | 2022-02-04 |
| AU2019201035B2 (en) | 2020-09-03 |
| JP2016502843A (ja) | 2016-02-01 |
| US20140199712A1 (en) | 2014-07-17 |
| KR102227321B1 (ko) | 2021-03-12 |
| JP6484178B2 (ja) | 2019-03-13 |
| IL239213B (en) | 2020-03-31 |
| AU2019201035B9 (en) | 2021-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201504520XA (en) | Compositions and methods for capture of cellular targets of bioactive agents | |
| IL269166A (en) | Methods and preparations for treating inflammation | |
| IL238943B (en) | Controlled release preparations and methods of using them | |
| IL237315A0 (en) | Method and preparations for cellular immunotherapy | |
| AP3965A (en) | Anthelminitic compounds and compositions and method of using thereof | |
| ZA201502880B (en) | Compositions and methods for immunotherapy | |
| IL252566B (en) | Pharmacy preparations and methods | |
| IL238416A0 (en) | Preparations and methods for the treatment of diseases caused by protein pathology | |
| PT2776567T (pt) | Composições e métodos para o tratamento de citomegalovírus | |
| ZA201408594B (en) | Xylitol-based anti-mucosal compositions and related methods and compositions | |
| GB201411762D0 (en) | Precoating methods and compositions | |
| GB201315350D0 (en) | Methods and compositions | |
| ZA201308892B (en) | Compositions and methods | |
| GB201315347D0 (en) | Methods and compositions | |
| HUE045495T2 (hu) | Szabályozott felszabadulású készítmények és alkalmazási eljárásaik | |
| EP2852370A4 (en) | FLASH-CONTAINING COMPOSITIONS AND METHODS OF USE | |
| GB201208315D0 (en) | Pharmaceutical methods and compositions | |
| GB201116340D0 (en) | Compositions and methods |